Let’s prevent diabetes: study protocol for a cluster randomised controlled trial of an educational intervention in a multi-ethnic UK population with screen detected impaired glucose regulation

详细信息    查看全文

• 作者：Laura J Gray (1)
  Kamlesh Khunti (1)
  Sian Williams (2)
  Stephanie Goldby (2)
  Jacqui Troughton (2)
  Thomas Yates (3)
  Alastair Gray (4)
  Melanie J Davies (3) (5)
  
• 关键词：Type 2 diabetes ; Prevention ; Impaired glucose regulation ; Cluster randomised controlled trial ; Screening
• 刊名：Cardiovascular Diabetology
• 出版年：2012
• 出版时间：December 2012
• 年：2012
• 卷：11
• 期：1
• 全文大小：305KB
• 参考文献：1. Kuznik A, Mardekian J: Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-008. / Cardiovasc Diabetol 2011, 10:31. CrossRef
  2. World Health Organization: / global health risks: mortality and burden of disease attributable to selected major risk factors. World Health Organization, Geneva; 2009.
  3. Zhang P, / et al.: Global healthcare expenditure on diabetes for 2010 and 2030. / Diabetes Res Clin Pract 2010, 87:293-01. j.diabres.2010.01.026">CrossRef
  4. Khunti K, / et al.: Unanswered questions over NHS health checks. / BMJ 2011, 342:316-18. j.d316">CrossRef
  5. Gillies CL, / et al.: Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. / BMJ 2007, 334:299. j.39063.689375.55">CrossRef
  6. Lauritzen T, Borch-Johnsen K, Sandbaek A: Is prevention of type 2 diabetes feasible and efficient in primary care? A systematic PubMed review. / Prim Care Diabetes 2007, 1:5-1. j.pcd.2006.11.001">CrossRef
  7. Yates T, Khunti K, Davies MJ: Prevention of diabetes: a reality in primary care? / Prim Care Diabetes 2007, 1:119-21. j.pcd.2007.07.003">CrossRef
  8. Absetz P, / et al.: Type 2 diabetes prevention in the "real world: three-year results of the GOAL Implementation Trial. / Diabetes Care 2009, 32:1418-420. CrossRef
  9. Ackermann RT, / et al.: Translating the diabetes prevention program into the community: the deploy pilot study. / Am J Prev Med 2008, 35:357-3. j.amepre.2008.06.035">CrossRef
  10. Laatikainen T, / et al.: Prevention of type 2 diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green Triangle (GGT) Diabetes Prevention Project. / BMC Public Health 2007, 7:249. CrossRef
  11. Schwarz PE, / et al.: Development of a diabetes prevention management program for clinical practice. / Public Health Rep 200, 122:258-63.
  12. Yates T, / et al.: Effectiveness of a pragmatic education programme aimed at promoting walking activity in individuals with impaired glucose tolerance: a randomized controlled trial. / Diabetes Care 2009, 32:1404-0. CrossRef
  13. Yates T, / et al.: The Prediabetes Risk Education and Physical Activity Recommendation and Encouragement (PREPARE) programme study: are improvements in glucose regulation sustained at two years? / Diabet Med 2011, 10:1268-271. j.1464-5491.2011.03357.x">CrossRef
  14. Excellence., N.I.f.H.a.C: / Type 2 diabetes: National clinical guideline for management in primary and secondary care (update). Royal Collage of Physicians, London; 2008.
  15. UK., D.o.H.D: / Structured patient education in diabetes: Report from the Patient Education Working Group. Department of Health, London; 2005.
  16. Gillett M, / et al.: Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis. / BMJ 2010, 341:c4093. j.c4093">CrossRef
  17. Waugh N, / et al.: Screening for type 2 diabetes: literature review and economic modelling. / Health Technol Assess 2007,11(17):1-25.
  18. Eborall H, / et al.: Influences on the uptake of diabetes screening: a qualitative study in primary care. / Br J Gen Pract 2012,62(596):e204-1. jgp12X630106">CrossRef
  19. Webb DR, / et al.: Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study. / Diabetologia 2011,54(9):2237-6. CrossRef
  20. Goyder E, / et al.: / National evaluation of DHDS Diabetes Screening Pilot Programme. Final Report. School of Health and Related Research, University of Sheffield; 2008.
  21. Sargeant LA, / et al.: Who attends a UK diabetes screening programme? Findings from the ADDITION-Cambridge study. / Diabet Med 2010,27(9):995-003. j.1464-5491.2010.03056.x">CrossRef
  22. Schwarz P, / et al.: Non-pharmacological intervention for diabetes mellitus prevention in populations: Where do we stand. / Nat Rev Endocrinol 2012.
  23. Collins GS, / et al.: Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. / BMC Med 2011, 9:103. CrossRef
  24. Gray LJ, / et al.: Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting. / Diabetologia 2012,55(4):959-96. CrossRef
  25. World Health Organisation: / Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications. Report of a WHO consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. World Health Organisation, Geneva; 1999.
  26. Office of the Deputy Prime Minister: [http://www.communities.gov.uk/communities/neighbourhoodrenewal/deprivation/deprivation07/] / The English Indices of Deprivation 2007 (Revised). ODPM Publications, London; 2007. webcite and 2007
  27. Roe L, / et al.: Dietary intervention in primary care: Validity of the DINE method for diet assessment. / Fam Pract 1994, 11:375-81. CrossRef
  28. Sintonen H, Pekurinen M, / et al.: A fifteen-dimensional measure of health-related quality of life (15D) and its applications. Kirjassa. In / Quality of Life Assessment: Key Issues in the 1990s. Edited by: Walker SR. Kluver Academic Publishers, Dordrecht; 1992:185-95.
  29. Zigmond A, Snaith R: The hospital anxiety and depression scale. / Acta Psychiatr Scand 2006, 67:361-0. j.1600-0447.1983.tb09716.x">CrossRef
  30. Broadbent E, / et al.: The brief illness perception questionnaire. / J Psychosom Res 2006, 60:631-37. j.jpsychores.2005.10.020">CrossRef
  31. Craig CL, / et al.: International physical activity questionnaire: 12-country reliability and validity. / Medicine and science in sports and exercise 2003, 35:1381-395. CrossRef
  32. Kita T, / et al.: Short sleep duration and poor sleep quality increase the risk of diabetes in Japanese workers with no family history of diabetes. / Diabetes Care 2012,35(2):313-. CrossRef
  33. Craig P, / et al.: Developing and evaluating complex interventions: the new Medical Research Council guidance. / BMJ 2008, 337:a1655. j.a1655">CrossRef
  34. Frei A, / et al.: The Chronic CARe for diAbeTes study (CARAT): a cluster randomized controlled trial. / Cardiovascular Diabetology 2010., 9:
  35. Shah BR, / et al.: Evaluation of a toolkit to improve cardiovascular disease screening and treatment for people with type 2 diabetes: protocol for a cluster-randomized pragmatic trial. / Trials 2010, 11:44. CrossRef
  36. Jansink R, / et al.: Nurse-led motivational interviewing to change the lifestyle of patients with type 2 diabetes (MILD-project): protocol for a cluster, randomized, controlled trial on implementing lifestyle recommendations. / BMC Health Serv Res 2009, 9:19. CrossRef
  37. Webb D, / et al.: Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening. / Trials 2010,19(11):16. CrossRef
  38. Kind P, / et al.: Variations in population health status: results from a United Kingdom national questionnaire survey. / BMJ 1998, 316:736-41. j.316.7133.736">CrossRef
  39. Leventhal H, Meyer D, Nerenz D: The common sense representation of illness danger. In / Medical psychology (Vol II, pp.7-0). Edited by: Rachman S. Pergamon Press, New York; 1980.
  40. Chaiken S: The Heuristic model of persuasion, in Social influence. In / The Ontario symposium. Edited by: Zanna MP, Olson JM, Herman CP. Erlbaum, Hillsdale; 1987:3-9.
  41. Bandura A: / Self-efficacy: The exercise of control. W.H. Freeman, New York; 1997.
  42. Gollwitzer PM: Implementation intentions: strong effects of simple plans:How can good intentions become effective behaviour change strategies? / American Psychologist 1999, 54:493-03. CrossRef
  43. Funnell MM, / et al.: Empowerment: an idea whose time has come in diabetes education. / Diabetes Educator 1992, 17:37-1. CrossRef
  44. Diabetes Prevention Programme Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intrevention and metformin. / New ENgland Journal of Medicine 2002, 346:393-03. CrossRef
  45. Tuomilehto J, / et al.: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. / The New England journal of medicine 2001,344(18):1343-350. CrossRef
  46. Davies MJ, Heller S, Skinner TC, Campbell MJ, Carey ME, Cradock S, Dallosso HM, Daly H, Doherty Y, Eaton S, Fox C, Oliver L, Rantell K, Rayman G, Khunti K, on behalf of the Diabetes Education and Self Management for Ongoing and Newly Diagnosed Collaborative: Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. / British Medical Journal 2008, 336:491-95. j.39474.922025.BE">CrossRef
  47. Stone M, / et al.: Using qualitative research methods to inform the development of a modified version of a patient education module for non English speakers with type 2 diabetes: experiences from an action research project on two south asian populations in the UK. / Diversity in health and Social Care 2008, 3:199-06.
  48. D'Agostino RB, / et al.: Validation of the framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. / JAMA 2001,286(2):180-. jama.286.2.180">CrossRef
  49. Expert Panel On Detection: E., And Treatment Of High Blood Cholesterol In Adults,, Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). / JAMA 2001,285(19):2486-7. jama.285.19.2486">CrossRef
  50. Ramachandran A, / et al.: The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). / Diabetologia 2006,49(2):289-97. CrossRef
  51. Lindstr?m J, / et al.: The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. / Diabetes Care 2003,26(12):3230-. CrossRef
  52. Yamaoka K, Tango T: Efficacy of lifestyle education to prevent type 2 diabetes: a meta-analysis of randomized controlled trials. / Diabetes Care 2005, 28:2780-786. CrossRef
  53. Yates T, / et al.: The role of physical activity in the management of impaired glucose tolerance: a systematic review. / Diabetologia 2007, 50:1116-126. CrossRef
  54. Campbell MK, Elbourne DR ADG: CONSORT statement: extension to cluster randomised trials. / BMJ 2004,328(7441):702-08. j.328.7441.702">CrossRef
  55. Paulweber B, / et al.: A European evidence-based guideline for the prevention of type 2 diabetes. / Horm Metab Res 2010,42(Suppl. 1):42.
  56. Programme TD [ject.org.uk/.24/04/2012" class="a-plus-plus">http://www.desmond-project.org.uk/.24/04/2012]
  57. Walker N, / et al.: The vascular risk assessment programme: implications for the delivery in primary care. / Diabetes and Primary Care 2009, 11:4.
  58. National Institute for Health and Clinical Excellence: / Public Health Draft Guidence, Preventing type 2 diabetes: risk identification and interventions for individuals at high risk. National Institute for Health and Clinical Excellence, London; 2011.
  
• 作者单位：Laura J Gray (1)
  Kamlesh Khunti (1)
  Sian Williams (2)
  Stephanie Goldby (2)
  Jacqui Troughton (2)
  Thomas Yates (3)
  Alastair Gray (4)
  Melanie J Davies (3) (5)
  
  1. Department of Health Sciences, University of Leicester, Leicester, UK
  2. Diabetes Research, University Hospitals of Leicester, Leicester, UK
  3. Department of Cardiovascular Sciences, University of Leicester, Leicester, UK
  4. Health Economics Research Centre, Department of Public Health, University of Oxford, Oxford, UK
  5. Department of Cardiovascular Sciences, Leicester Diabetes Centre (Broadleaf), Leicester General Hospital, University of Leicester, Gwendolen Road, Leicester, LE5 4PW, UK
  

文摘

Background The prevention of type 2 diabetes is a globally recognised health care priority, but there is a lack of rigorous research investigating optimal methods of translating diabetes prevention programmes, based on the promotion of a healthy lifestyle, into routine primary care. The aim of the study is to establish whether a pragmatic structured education programme targeting lifestyle and behaviour change in conjunction with motivational maintenance via the telephone can reduce the incidence of type 2 diabetes in people with impaired glucose regulation (a composite of impaired glucose tolerance and/or impaired fasting glucose) identified through a validated risk score screening programme in primary care. Design Cluster randomised controlled trial undertaken at the level of primary care practices. Follow-up will be conducted at 12, 24 and 36 months. The primary outcome is the incidence of type 2 diabetes. Secondary outcomes include changes in HbA1c, blood glucose levels, cardiovascular risk, the presence of the Metabolic Syndrome and the cost-effectiveness of the intervention. Methods The study consists of screening and intervention phases within 44 general practices coordinated from a single academic research centre. Those at high risk of impaired glucose regulation or type 2 diabetes are identified using a risk score and invited for screening using a 75 g-oral glucose tolerance test. Those with screen detected impaired glucose regulation will be invited to take part in the trial. Practices will be randomised to standard care or the intensive arm. Participants from intensive arm practices will receive a structured education programme with motivational maintenance via the telephone and annual refresher sessions. The study will run from 2009-014. Discussion This study will provide new evidence surrounding the long-term effectiveness of a diabetes prevention programme conducted within routine primary care in the United Kingdom. Trial registration Clinicaltrials.gov NCT00677937